A real-world retrospective study to assess efficacy and safety of alectinib as adjuvant therapy in IB-IIIB NSCLC patients harboring ALK rearrangement

Overview of attention for article published in Frontiers in oncology, October 2024

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 Reddit thread.

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.